[Modulation with phorbol myristate acetate and staurosporine  of interleukin 2- induced proliferation and nonspecific cytotoxicity of rat lymphocytes].
Anisimov
A G
AG
Bolotnikov
I A
IA
D000818:Animals; D002273:Carcinogens / Q000494:pharmacology*; D002455:Cell Division / Q000187:drug effects; D002478:Cells, Cultured; D003602:Cytotoxicity, Immunologic / Q000187:drug effects*; D007376:Interleukin-2 / Q000494:pharmacology*; D008213:Lymphocyte Activation / Q000187:drug effects*; D008214:Lymphocytes / Q000187:drug effects / Q000276:immunology*; D008297:Male; D051381:Rats; D017208:Rats, Wistar; D019311:Staurosporine / Q000494:pharmacology*; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology*
D002273:Carcinogens; D007376:Interleukin-2; D019311:Staurosporine; D013755:Tetradecanoylphorbol Acetate
Moduliatsiia indutsirovannoi' interlei'kinom-2 proliferatsii i     nespetsiskoi' tsitotoksichnosti limfotsytov krys forbolmiristatatsetatom i staurosporinom.